Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: May 2026 and Jul 2026.
- Largest single sale: $1.5M (8,433 shares) of Neurocrine Biosciences Inc on Jul 9, 2026. Filing
- Last sale before this period: Jul 10, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Neurocrine Biosciences Inc (NBIX) | Chief Regulatory Officer | Feb 15, 2023 | Sep 15, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 11, 2026, Neurocrine Biosciences Inc: 4,483 shares awarded; 2,419 shares withheld by the company for taxes. 1 filing: 1
- Jul 10, 2026, Neurocrine Biosciences Inc: sold 4,367 shares for $791K, under a disclosed plan; 4,367 shares acquired by exercising options. 1 filing: 1
- Jul 9, 2026, Neurocrine Biosciences Inc: sold 8,433 shares for $1.5M, under a disclosed plan; 8,433 shares acquired by exercising options. 1 filing: 1
- Jul 8, 2026, Neurocrine Biosciences Inc: sold 2,737 shares for $489K, under a disclosed plan; 2,737 shares acquired by exercising options. 1 filing: 1
- Jul 7, 2026, Neurocrine Biosciences Inc: sold 3,401 shares for $607K, under a disclosed plan; 3,401 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.